Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04397939 · ClinicalTrials.gov registry record
Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 4,695
- Enrollment target
NCT04397939 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 4,695 participants.
The verdict
NCT04397939 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 4,695 participants
- Enrollment target
Study Summary
The study will analyze the incidence, clinical outcomes and predictors of myocardial injury in a large patient population with COVID-19 treated in Mount Sinai Hospital (MSH) system. In addition, the study team will explore the association between high-sensitivity troponin I (TnI) levels and clinical characteristics, biomarkers, cardiac tests data and treatment approaches to uncover the potential mechanisms responsible for COVID-19 induced myocardial injury.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,695 participants |
| Start Date | 2020-05-08 |
| Est. Completion | 2022-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04397939
The ClinicalTrials.gov registry entry for NCT04397939 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,695 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04397939 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04397939 about?
NCT04397939 is a clinical study titled "Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19". The study will analyze the incidence, clinical outcomes and predictors of myocardial injury in a large patient population with COVID-19 treated in Mount Sinai Hospital (MSH) system. In addition, the study team will explore the association between high-sensitivity troponin I (TnI) levels and clinical...
What is the current status of trial NCT04397939?
This trial is currently completed. The enrollment target is 4,695 participants. The study started on 2020-05-08. Estimated completion is 2022-03-01.
Who is sponsoring clinical trial NCT04397939?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.